Skip to main content

Scribe Therapeutics - Rewriting The Story of Disease

Scribe Therapeutics - Rewriting The Story of Disease

Headquarters : 1150 Marina Village Pkwy, Alameda, CA 94501

Genetic predisposition shouldn’t dictate your health destiny. We’re committed to unlocking the future of medicine by engineering CRISPR-based therapeutics that are safe and effective enough to transform everyone's lifetime risk for disease.

Founded with Nobel Prize-winning science, Scribe is working to maximize human health with safe, effective genetic medicines for everyone.
We accomplish this with molecular engineering – taking natural CRISPR systems and comprehensively modifying them into the most specific and potent therapies possible.
Today, we’re designing a portfolio of treatments for humanity’s leading killer, cardiometabolic disease (CMD).

CrISPR By Design
This future is only possible with CRISPR genetic medicines precisely engineered for safety and potency

Engineering by Design
CRISPR medicine shouldn’t take shortcuts. Our comprehensive molecular engineering approach takes small, iterative, and intentional steps to develop CRISPR-based medicines designed to be safe and specific enough enough to help millions of

Portfolio by Design
We’ve engineered purpose-built CRISPR-based therapeutics to have the broadest possible impact, starting with the leading cause of death globally — cardiometabolic disease.

Comments